Blue Water Life Science Advisors, LP Adaptive Biotechnologies Corp Transaction History
Blue Water Life Science Advisors, LP
- $126 Million
- Q2 2025
A detailed history of Blue Water Life Science Advisors, LP transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Blue Water Life Science Advisors, LP holds 2,145,145 shares of ADPT stock, worth $27.2 Million. This represents 19.78% of its overall portfolio holdings.
Number of Shares
2,145,145
Previous 2,145,145
-0.0%
Holding current value
$27.2 Million
Previous $15.9 Million
56.8%
% of portfolio
19.78%
Previous 15.79%
Shares
9 transactions
Others Institutions Holding ADPT
# of Institutions
261Shares Held
149MCall Options Held
168KPut Options Held
25.2K-
Viking Global Investors LP30MShares$380 Million1.11% of portfolio
-
Black Rock Inc. New York, NY11.7MShares$148 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.3MShares$143 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY6.26MShares$79.2 Million1.68% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.4.3MShares$54.4 Million0.03% of portfolio
About Adaptive Biotechnologies Corp
- Ticker ADPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 142,872,992
- Market Cap $1.81B
- Description
- Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...